Table 1.
Clinicopathological characteristics of the human patients included in the study. NAFLD diagnoses were established histologically21.
| Group | N (males) | Age (years) | BMI (kg/m2) | AST (IU) | ALT (IU) | Glucose (mM) | Cholesterol (mM) | Triglycerides (mM) |
|---|---|---|---|---|---|---|---|---|
| S0 | 9 (0) | 35.0 ± 3.5 | 47.0 ± 1.9 | 23.3 ± 2.3 | 25.1 ± 3.2 | 5.0 ± 0.2 | 4.8 ± 0.2 | 1.2 ± 0.2 |
| S1 | 8 (0) | 43.8 ± 3.8 | 45.4 ± 1.7 | 21.8 ± 3.5 | 24.8 ± 3.1 | 5.0 ± 0.2 | 6.2 ± 0.6 | 1.9 ± 0.4 |
| S2 | 7 (0) | 41.2 ± 5.1 | 43.5 ± 2.0 | 24.9 ± 2.3 | 34.9 ± 3.2 | 5.2 ± 0.2 | 5.6 ± 0.7 | 1.6 ± 0.2 |
| S3 | 9 (0) | 39.9 ± 4.7 | 45.5 ± 2.7 | 27.8 ± 2.5 | 40.8 ± 7.2 | 5.3 ± 0.2 | 4.8 ± 0.4 | 1.4 ± 0.2 |
| S3 + NASH | 9 (1) | 44.6 ± 3.5 | 43.2 ± 1.5 | 32.8 ± 3.2 | 44.6 ± 5.6 | 5.5 ± 0.4 | 5.1 ± 0.3 | 1.4 ± 0.2 |
Values are given as mean ± 1 standard error of the mean. ALT, a known biomarker of liver damage, is the only parameter found significantly altered (p < 0.05) between the groups of patients under comparison.